Ruifuda
Latest round
- Series B
Last raised
- Jun 2025
Total raised
- Undisclosed
Investors
- 2
About Ruifuda
Founded in 2018 in Lianyungang, China, Ruifuda focuses on assisted reproduction technologies.Ruifuda provides a comprehensive suite of assisted reproductive technologies designed to address various challenges in fertility treatments. Their core offerings include innovative medical solutions that enhance operational efficiency for healthcare providers.Ruifuda generates revenue through a diverse transaction structure that includes direct sales of its reproductive health technologies and partnerships with healthcare facilities. Clients typically engage with the firm through subscription models for ongoing support, complemented by bulk purchases of flagship technologies., Ltd. The company plans to utilize these funds for technology research and development of core products, expand into domestic and overseas markets, upgrade capacity, and enhance team building initiatives. Specific strategies for market development include targeting new geographic regions to increase their presence in the assisted reproduction industry.
Who invested in Ruifuda
2 investors across 1 round
See all investors in Ruifuda
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 11, 2025
Amount
Undisclosed
Investors
Questions about Ruifuda
Who invested in Ruifuda?
Ruifuda has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ruifuda raised?
Ruifuda has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ruifuda last raise money?
Ruifuda's most recent round on record is a Series B, in Jun 2025.
What does Ruifuda do?
Founded in 2018 in Lianyungang, China, Ruifuda focuses on assisted reproduction technologies.
Where is Ruifuda headquartered?
Ruifuda is headquartered in Lianyungang, China.
Which VCs invest in companies like Ruifuda?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Ruifuda's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ruifuda? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.